Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.
about
Functionally Diverse NK-Like T Cells Are Effectors and Predictors of Successful AgingThe relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder.Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?The potential role of vagus-nerve stimulation in the treatment of HIV-associated depression: a review of literature.Inflammatory cytokine-associated depressionThe effects of EGb761 on lipopolysaccharide-induced depressive-like behaviour in C57BL/6J micePotential unfavorable impacts of BDNF Val66Met polymorphisms on metabolic risks in average population in a longevous area.A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays.Polyunsaturated fatty acids moderate the effect of poor sleep on depression riskLow-grade inflammation predicts persistence of depressive symptomsVal66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancerInterplay between pro-inflammatory cytokines and growth factors in depressive illnessesGlucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression.Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids.Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.Depression in Late-Life: a Focus on PreventionMood disturbance after infection.Fighting insomnia and battling lethargy: the yin and yang of palliative care.Sick and tired: mood, fatigue, and inflammation in cancer.The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery.Evaluation of the effect of soybean diet on interferon-α-induced depression in male mice.Val66Met polymorphism association with serum BDNF and inflammatory biomarkers in major depression.Translational Functional Neuroimaging in the Explanation of Depression.Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.Therapeutic strategies for treatment of inflammation-related depression.Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).
P2860
Q28077020-9FA1149A-D786-4FF2-8B8E-89A32200898FQ33578766-CB84AA70-D23A-42AA-B16B-E944CDBB87CEQ33645706-59BDF717-FB5A-43EC-801C-BD5D5A6CE50AQ33879231-A7947C6E-E696-4C44-B2C0-1443E3FE9EFDQ34825010-6D03FE84-E086-473F-B4CE-AD948F634B43Q35756286-CD8AFA26-2DD3-4476-819C-F38F7C13D7B0Q36240927-58F13CB1-8B83-4652-A701-4D680E3F4DA6Q36361793-8E967F20-24CB-4EC3-86BD-1931DFBBFD4FQ36642579-32C3B57E-43C1-4EFD-A999-0B226B3A2675Q36789300-D1A8B1DE-A106-46D4-92F2-ECBF069B9BC3Q36813475-F928AA7E-6956-4B49-8705-BD9A8A37E2A2Q36832872-F9FC97B1-3D12-4115-8E16-8DC357BB13E0Q36852421-E43CB731-0FB2-411D-BF46-7E8A4A6EBF9BQ37089253-B72F69FB-529E-4A49-B847-4B0BAC7D6F10Q37171783-1915AE61-AFDF-49AF-B69E-EF89157DD4AFQ37279534-8363EA29-687C-4599-A74B-19971BB2C1DAQ37668003-E4C1B92F-E8EA-423B-A384-B91E28C1C97FQ37696221-596B0FE6-E05B-4FF8-A936-83207EC6AB7BQ38140646-6D61A95A-647A-4135-B9EE-A93ECD66DEC7Q38188834-9FD45FE3-D35E-4315-8023-47330E8D2AB3Q38363925-C827B361-77B7-473B-AECD-602F8C73D496Q39157253-0C691ECD-D336-4808-99B8-06BD8B30D24CQ46744795-C394EAFA-861F-4612-A7DF-21B73CA4AD93Q47111657-CE2EF1AB-461B-4AE8-BF89-9262E02A8261Q47716762-9C901585-A121-4C4B-8EAA-A753238913FDQ47743048-14357A6E-1746-4766-AB4B-292905587559Q47785431-55E3ED72-1756-4AEC-846F-0D59500CF378Q47785792-3E715A32-9E59-46A5-9BA6-30CB48F85BA6Q48078497-2A1AA40A-B9DB-4D96-8986-B107A97905F1
P2860
Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Brain-derived neurotrophic fac ...... during interferon-α treatment.
@ast
Brain-derived neurotrophic fac ...... during interferon-α treatment.
@en
type
label
Brain-derived neurotrophic fac ...... during interferon-α treatment.
@ast
Brain-derived neurotrophic fac ...... during interferon-α treatment.
@en
prefLabel
Brain-derived neurotrophic fac ...... during interferon-α treatment.
@ast
Brain-derived neurotrophic fac ...... during interferon-α treatment.
@en
P2093
P2860
P356
P1476
Brain-derived neurotrophic fac ...... during interferon-α treatment.
@en
P2093
Francis E Lotrich
Robert E Ferrell
Salwa Albusaysi
P2860
P2888
P304
P356
10.1038/NPP.2012.263
P407
P577
2012-12-18T00:00:00Z